Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02531529

Enrollment

Registered

2015-08-24

Start date

2014-01-31

Completion date

2015-04-30

Last updated

2015-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Donor Hepatectomy

Brief summary

To compare between the analgesic effect of dexmedetomedine infusion versus Fentanyl infusion during donor hepatectomy.

Interventions

DRUGdexmedetomedine

intraoperative infusion

DRUGFentanyl

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

20 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* donors of living donor liver transplantation

Exclusion criteria

* patient refusal Known allergy to dexmedetomedine

Design outcomes

Primary

Measure	Time frame
postoperative VAS scale	3 days

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026